| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/29/1999 | CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/29/1999 | CN1230184A Arylamino fused pyridines and pyrimidines |
| 09/29/1999 | CN1230110A Cell adhesion inhibitors |
| 09/29/1999 | CN1045293C Substituted pyrazoles compounds and medicinal compositions containing same |
| 09/28/1999 | US5958953 Substituted indazole derivatives |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958941 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs |
| 09/28/1999 | US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 09/28/1999 | US5958910 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides |
| 09/28/1999 | US5958905 Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
| 09/28/1999 | US5958891 Administering vector comprising gene encoding dust mite allergen by intramuscular injection to prevent airway hyperreactivity or airway inflammation |
| 09/28/1999 | US5958882 Compounds that inhibit T cell proliferation and methods using the same |
| 09/28/1999 | US5958880 Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof |
| 09/28/1999 | US5958772 Antisense inhibition of cellular inhibitor of apoptosis-1 expression |
| 09/28/1999 | US5958771 Oligonucleotide from 8 to 30 nucleotides in length; for diagnosis and therapy; antitumor/antiinflammatory agents |
| 09/28/1999 | US5958726 Polynucleotide sequence of clone h84924 accession number atcc 98028; has signal sequence; for diagnosis and treatment of related diseases |
| 09/28/1999 | US5958718 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 09/28/1999 | US5958712 Identifying altered t cell receptor ligand comprising major histocompatible complex and peptide that inhibits t cell effector response |
| 09/28/1999 | US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder |
| 09/28/1999 | US5958708 The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy. |
| 09/28/1999 | US5958683 Screening method using the RZR receptor family |
| 09/28/1999 | US5958425 Viral vaccines |
| 09/28/1999 | US5958419 Comprising fermented extract form plant tissue of stevia and an organic acid; no side effects |
| 09/28/1999 | US5958416 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
| 09/28/1999 | US5958415 Protein allergen of Derf II and composition |
| 09/28/1999 | US5958414 An isolated bartionella henselae antigen comprising whole inactivated bartionella henselae cells and an adjuvant comprising poly(di(carboxylatophenoxy)phosphazene; culture product |
| 09/28/1999 | US5958409 Administering antitumor necrosis factor antibody to the human suffering with multiple sclerosis |
| 09/28/1999 | US5958403 Localized immunosuppression by insertion of nucleic acid sequence encoding cytotoxic t-cell lymphocyte antigen-immunoglobulin operably linked to promoter into an islet cell, ex vivo |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/23/1999 | WO1999047929A1 Development of human monoclonal antibodies and uses thereof |
| 09/23/1999 | WO1999047708A1 Antisense modulation of pecam-1 |
| 09/23/1999 | WO1999047707A1 Antisense modulation of lfa-3 |
| 09/23/1999 | WO1999047703A1 Method for producing agents for treating tumour diseases and for immunosuppression |
| 09/23/1999 | WO1999047687A1 Enhanced anti-tumor immunity |
| 09/23/1999 | WO1999047675A1 Mu-1, member of the cytokine receptor family |
| 09/23/1999 | WO1999047673A2 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | WO1999047641A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 09/23/1999 | WO1999047564A1 Fas-associated polypeptides |
| 09/23/1999 | WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047534A1 Compounds having immunomodulatory effects |
| 09/23/1999 | WO1999047533A1 Compounds having immunomodulatory effects |
| 09/23/1999 | WO1999047529A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 09/23/1999 | WO1999047512A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 09/23/1999 | WO1999047169A1 Methods to provoke anti-cancer immune responses |
| 09/23/1999 | WO1999047168A2 Induction and enhancement of the immune response to type-2 t cell-independent antigens conjugated to lipid or lipid-containing moieties |
| 09/23/1999 | WO1999047167A1 Double mutant enterotoxin for use as an adjuvant |
| 09/23/1999 | WO1999047166A1 IMMUNOMODULATORY FRAGMENTS OF POLYCLONAL ANTILYMPHOCYTE GLOBULINS (ALGs) AND USES THEREOF |
| 09/23/1999 | WO1999047165A1 Production of purified mutant enterotoxin for use as an adjuvant |
| 09/23/1999 | WO1999047164A1 Use of mutant enterotoxin with excess b-subunit as an adjuvant |
| 09/23/1999 | WO1999047163A2 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 09/23/1999 | WO1999047162A1 Products in the treatment of cancer |
| 09/23/1999 | WO1999047158A2 Therapeutic chemokine receptor antagonists |
| 09/23/1999 | WO1999047154A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | WO1999047102A2 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby |
| 09/23/1999 | WO1999046992A1 Induction of immunity against tumor self-antigens |
| 09/23/1999 | WO1999041374A3 Human short-chain tnf-receptor family protein |
| 09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
| 09/23/1999 | WO1999041355A3 Hiv chemokines |
| 09/23/1999 | WO1999039736A3 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES |
| 09/23/1999 | WO1998015284A3 Mycosis vaccines |
| 09/23/1999 | CA2324337A1 Products in the treatment of cancer |
| 09/23/1999 | CA2323439A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | CA2323083A1 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | CA2322660A1 Enhanced anti-tumor immunity |
| 09/23/1999 | CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 09/23/1999 | CA2319493A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943625A1 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method of the hybridomas and antigen proteins recognized by the antibodies |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0943606A1 Benzenesulfonamide derivatives and drugs containing the same |
| 09/22/1999 | EP0943339A2 Method of preventing allograft rejection |
| 09/22/1999 | EP0942998A1 Notch |
| 09/22/1999 | EP0942997A1 Chimeric ltb vaccines |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942973A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 09/22/1999 | EP0942902A2 Novel immunotherapeutic imides/amides |
| 09/22/1999 | EP0942896A1 Substituted phenols and thiophenols useful as antioxidant agents |
| 09/22/1999 | EP0942750A1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | CN1229439A Fusion polypeptides comprising an IgE-binding domain and a HSA component, and their diagnostic and therapeutic uses |
| 09/22/1999 | CN1229414A Multivalent compounds for cross-linking receptors and uses thereof |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229407A Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 09/22/1999 | CN1229359A Dendritic cell stimulatory factor |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1228973A Pseudo-ginseng extract soft capsule and preparation technology thereof |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955492 Carboxylic acid indole inhibitors of chemokines |
| 09/21/1999 | US5955469 17-allyl-1,14-dihydroxy-12-(2-(4-hydroxy-3-methoxycyclohexyl)-1 -methylvinyl)-23,25-dimethoxy-12,19,21,27-tetramethyl-11,28-d ioxa-4-azatricyclo(22.3.1.0)octacos-18-18-ene-2,3,10,16-tetrao ne; lecithin, soybean oil; oil in water; immunosuppressants |
| 09/21/1999 | US5955462 Antiinflammatory agents for neurogenic inflammation and administering bisindole or compounds |
| 09/21/1999 | US5955457 Water soluble rapamycin esters |
| 09/21/1999 | US5955443 Treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a platelet endothelial cell adhesion molecule-1 (pecam-1; also known as cd31 antigen or endocam) protein are |
| 09/21/1999 | US5955428 DNA encoding human metallothionein |
| 09/21/1999 | US5955424 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs |
| 09/21/1999 | US5955313 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |